Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2464| Título : | Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye |
| Creador: | Leal Leal, Carlos A |
| Nivel de acceso: | Open access |
| Palabras clave : | Retinoblastoma - terapia - niño Retinoblastoma - quimioterapía - niño Retinoblastoma - clasificación - niño Neoplasias de la Retina - terapia - niño Neoplasias de la Retina - quimioterapía - niño Arteria Oftálmica - niño Anestesia General - niño Topotecan - uso terapéutico - niño Melfalán - uso terapéutico - niño Retinoblastoma - therapy - child Retinoblastoma - chemotherapy - child Retinoblastoma - classification - child Retinal Neoplasms - therapy - child Retinal Neoplasms - chemotherapy - child Ophthalmic Artery - child Anesthesia, General - child Topotecan - therapeutic use - child Melphalan - therapeutic use - child Retinoblastoma. La quimioterapia intrarterial. Rescate de ocular. Melfalán. Topotecán. Retinoblastoma. Intra-arterial chemotherapy. Ocular rescue. Melphalan. Topotecan. |
| Descripción : | INTRODUCTION: Intra-arterial chemotherapy is a novel therapeutic modality for retinoblastoma patients. Intra-arterial chemotherapy involves the administration of a super-selective drug through the ophthalmic artery, resulting in better ocular penetration and low systemic toxicity. OBJECTIVE: The aim of this report was to evaluate the feasibility of intra-arterial chemotherapy in a large referral center in Mexico City. METHODS: We included patients with bilateral retinoblastoma, one enucleation, and active disease in the other eye after at least two courses of systemic chemotherapy combined with topical treatments. All patients were treated with three courses of a combination of melphalan 4 mg and topotecan 1 mg. Patients were examined under general anesthesia three weeks after each chemotherapy cycle. RESULTS: From 14 eligible patients, three could not be treated due to inaccessibility of the ophthalmic artery. A complete response was observed in 5/11 patients, three in Stage C according to the International Classification for Intraocular Retinoblastoma, one in Stage D, and one in Stage B. The eyes of three patients were enucleated as a result of active/progressive disease, one in Stage B and two in Stage D. Eye preservation was 55% after a mean follow-up of 171 days (range 21-336). |
| Colaborador(es) u otros Autores: | Asencio-López Laura Higuera-Calleja Jesús Bernal-Moreno Max Bosch-Canto Vanessa Chávez-Pacheco Juan Isaac-Otero Gabriela Beck-Popovic Maja |
| Fecha de publicación : | 2016 |
| Tipo de publicación: | Artículo |
| Formato: | |
| Fuente: | Rev Invest Clin 68(3):137-42 |
| URI : | http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2464 |
| Idioma: | spa |
| Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.